Helicos Cuts Q3 Net Loss by Almost 40 Percent; Rules out Potential Sale of Company

Helicos said that based on its "improving standalone prospects and current market valuation" that it has disengaged from discussions involving a potential sale of the company.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories